20112019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Elena Geuna is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?

Giannone, G., Milani, A., Geuna, E., Galizia, D., Biello, F. & Montemurro, F., Jan 2 2019, In : Expert Opinion on Pharmacotherapy. 20, 1, p. 5-9 5 p.

Research output: Contribution to journalEditorial

Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study

Galizia, D., Milani, A., Geuna, E., Martinello, R., Cagnazzo, C., Foresto, M., Longo, V., Berchialla, P., Solinas, G., Calori, A., Grasso, B., Volpone, C., Bertola, G., Parola, G., Tealdi, G., Giuliano, P. L., Ballari, A. M., Aglietta, M. & Montemurro, F., Sep 1 2018, In : Cancer Medicine. 7, 9, p. 4339-4344 6 p.

Research output: Contribution to journalArticle

  • What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?

    Giannone, G., Milani, A., Geuna, E., Galizia, D., Biello, F. & Montemurro, F., Nov 6 2018, In : Expert Opinion on Pharmacotherapy. p. 1-5 5 p.

    Research output: Contribution to journalArticle

    A first-in-human, Phase I, dose-escalation study of TAK-117, A selective PI3Ka isoform inhibitor, in patients with advanced solid malignancies

    Juric, D., De Bono, J. S., LoRusso, P. M., Nemunaitis, J., Heath, E. I., Kwak, E. L., Mercade, T. M., Geuna, E., De Miguel-Luken, M. J., Patel, C., Kuida, K., Sankoh, S., Westin, E. H., Zohren, F., Shou, Y. & Tabernero, J., Sep 1 2017, In : Clinical Cancer Research. 23, 17, p. 5015-5023 9 p.

    Research output: Contribution to journalArticle